Cargando…
LncRNA PITPNA-AS1 as a Potential Diagnostic Marker and Therapeutic Target Promotes Hepatocellular Carcinoma Progression via Modulating miR-448/ROCK1 Axis
Background: Long non-coding RNAs are critical to hepatocellular carcinoma (HCC) developments. LncRNA PITPNA antisense RNA 1 (PITPNA-AS1) is a new regulator in several tumors. However, the mechanism by which PITPNA-AS1 mediates the tumorigenesis of HCC remains unclear. Methods: RT-qPCR was used to de...
Autores principales: | Wang, Qing-fang, Wang, Qing-lin, Cao, Ming-bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149744/ https://www.ncbi.nlm.nih.gov/pubmed/34055841 http://dx.doi.org/10.3389/fmed.2021.668787 |
Ejemplares similares
-
lncRNA PITPNA-AS1 promotes cell proliferation and metastasis in hepatocellular carcinoma by upregulating PDGFD
por: Yao, Jianguo, et al.
Publicado: (2023) -
LncRNA PITPNA‐AS1/miR‐223‐3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma
por: Peng, Bi‐hao, et al.
Publicado: (2022) -
LncRNA NEAT1 Promotes the Malignant Progression of Colorectal Cancer
by Targeting ZEB1 via miR-448
por: Wu, Hanquan, et al.
Publicado: (2022) -
LncRNA PITPNA-AS1 promotes gastric cancer by increasing SOX4 expression via inhibition of miR-92a-3p
por: Liu, Licheng, et al.
Publicado: (2021) -
PITPNA-AS1/miR-98-5p to Mediate the Cisplatin Resistance of Gastric Cancer
por: Ma, Zhongling, et al.
Publicado: (2022)